Blog 15 October 2026 How patient organizations are driving rare disease drug development Patient organizations in rare disease are no longer waiting for pharma to act, and a growing number now... Learn more
Webinar How patient organizations are driving rare disease drug development Craig Lipset and Derk Arts on how patient organizations are driving rare disease drug development. Watch the webinar... Learn more
Factsheets 1 October 2026 Run your EU MDR PMCF program on one platform PMCF is a multi-year evidence commitment, the post-market clinical follow-up component of your EU MDR post-market surveillance obligations,... Learn more
